|

AN4005-dose level 1 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Adlai Nortye Biopharma Co., Ltd.1

Indications

  • Advanced Lymphoma1
  • Advanced Solid Tumor1
  • Cancer1

Hackensack, New Jersey1 trial

First in Human, Dose Escalation Study of AN4005

Hackensack University Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.